© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
The HCPLive ADHD condition center page is a comprehensive resource for clinical news and insights on ADHD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for ADHD.
July 22, 2021
CBGT and MBSR were both associated with a significant decrease in negative emotion.
July 09, 2021
Researchers found the strongest associations between ADHD and nervous system disorders and respiratory diseases.
July 01, 2021
Methylphenidate hydrochloride (Adhansia XR) was originally approved in 2019 for ADHD patients at least 6 years old.
June 16, 2021
Viloxazine was approved in April by the FDA for pediatric ADHD patients between 6-17 years old.
June 07, 2021
Externalizing ADHD symptoms was linked to suicidality.
June 03, 2021
Greater symptoms of depression, anxiety, and ADHD were associated with less sleep.
May 04, 2021
Andrew J. Cutler, MD discusses new research into the efficacy and safety of a D-ATS treatment in children with ADHD.
May 03, 2021
Impaired reward processing could influence the presentation of sleep disturbances for patients with ADHD.
May 02, 2021
Adults often do not suffer from the symptoms of hyperactivity in ADHD.
New data show ADHD-specific text message intervention beneficial to patients who may have low rate of stimulant treatment adherence.